Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-20

FDA Approved: LOTEPREDNOL ETABONATE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved the original application for Loteprednol etabonate ophthalmic drops from Amneal Pharmaceuticals NY LLC, providing a generic option for treating…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTEPREDNOL ETABONATE (Loteprednol etabonate)

Snippet

ORIG AP for LOTEPREDNOL ETABONATE (LOTEPREDNOL ETABONATE)